NPM1
MOLECULAR TARGETnucleophosmin 1
NPM1 (nucleophosmin 1) is targeted by 2 compounds in the BiohacksAI evidence corpus, derived from PubMed bioassay data. Each compound is ranked by confidence score (log-normalized assay count × evidence quality).
Compounds Targeting NPM1
Ranked by bioassay confidence score (PubChem active assay count × evidence quality).
| # | Compound | Confidence | Active Assays |
|---|---|---|---|
| 1 | molibresib | 3.81 | 44 |
| 2 | Crizotinib | 0.69 | 1 |
About NPM1 as a Drug Target
NPM1 (nucleophosmin 1) is a well-characterized molecular target in biomedical research. BiohacksAI tracks 2 compounds with documented NPM1 interaction from PubChem bioassay data, cross-referenced with PubMed clinical evidence. The confidence score reflects the log-normalized count of active PubChem assays, weighted by evidence quality from the BiohacksAI corpus.
NPM1 inhibitors, activators, and modulators are of interest in research areas including longevity, metabolic health, and neurological function. Each compound profile includes evidence score, RCT count, human study ratio, research velocity, and domain relevance.